1 Weitsman T, Weisz G, Farkash R et al. Pulmonary hypertension with left heart disease: prevalence, temporal shifts in etiologies and outcome. Am J Med, 2017,130:1272-79.
2 D'Alto M, Bossone E, Opotowsky AR, Ghio S, Rudski LG, Naeije R.Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension. Int J Cardiol, 2018, 263:177-183.
3 Jardim C, Souza R. Biomarkers and prognostic indicators in pulmonary arterial hypertension. Curr Hypertens Rep, 2015, 17:556.
4 Pezzuto B, Badagliacca R, Poscia R et al. Circulating biomarkers in pulmonary arterial hypertension: update and future direction. J Heart Lung Transplant, 2015,34:282-305.
5 Cracowski JL, Leuchte HH. The potential of biomarkers in pulmonary arterial hypertension. Am J Cardiol, 2012,110:32S-8S.
6 Machado RD, Southgate L, Eichstaedt CA et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat, 2015,36:1113-27.
7 Gerges M, Gerges C, Pistritto AM et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med, 2015,192:1234-46.
8 Vachiéry JL, Tedford RJ, Rosenkranz S et al. Pulmonary hypertension due to left heart disease. Eur Respir J, 2019,53:1801897.
9 Guazzi M, Ghio S, Adir Y. Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week. J Am Coll Cardiol, 2020, 76:1102-1111.
10 Rudski LG, Lai WW, Afilalo J et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr, 2010,23:685–713.
11 Allemann Y, Stuber T, de Marchi SF et al. Pulmonary artery pressure and cardiac function in children and adolescents after rapid ascent to 3,450 m. Am J Physiol Heart Circ Physiol, 2012,302:H2646-53.
12 Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Left ventricular heart failure and pulmonary hypertensiondagger. Eur Heart J, 2016,37:942-54.
13 Rosenthal JL, Jacob MS. Biomarkers in pulmonary arterial hypertension. Curr Heart Fail Rep, 2014, 11:477-84.
14 Casserly B, Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Des Devel Ther, 2009, 3:269-87.
15 Mahadavan G, Nguyen TH, Horowitz JD. Brain natriuretic peptide: a biomarker for all cardiac disease? Curr Opin Cardiol, 2014,29:160-6.
16 Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med, 2010,10:22.
17 Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int, 2005,67:1739-42.
18 Zharikov S, Krotova K, Hu H et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol, 2008,295:C1183-90.
19 Zharikov SI, Swenson ER, Lanaspa M, Block ER, Patel JM, Johnson RJ. Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses, 2010,74:1069-74.
20 Zhang CY, Ma LL, Wang LX. Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension. Exp Clin Cardiol, 2013,18:e37-9.
21 Fenster BE, Lasalvia L, Schroeder JD et al. Cystatin C: a potential biomarker for pulmonary arterial hypertension. Respirology, 2014,19:583-9.
22 Zhao QH, Peng FH, Wei H et al. Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol, 2012, 110:433-9.
23 Heresi GA, Aytekin M, Newman J, DiDonato J, Dweik RA. Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med, 2010,182:661-8.
24 Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart, 2011,97:1054-60.